• Je něco špatně v tomto záznamu ?

Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction

GM. Lynn, P. Chytil, JR. Francica, A. Lagová, G. Kueberuwa, AS. Ishizuka, N. Zaidi, RA. Ramirez-Valdez, NJ. Blobel, F. Baharom, J. Leal, AQ. Wang, MY. Gerner, T. Etrych, K. Ulbrich, LW. Seymour, RA. Seder, R. Laga,

. 2019 ; 20 (2) : 854-870. [pub] 20190122

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Intramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006667

Small molecule Toll-like receptor-7 and -8 agonists (TLR-7/8a) can be used as vaccine adjuvants to induce CD8 T cell immunity but require formulations that prevent systemic toxicity and focus adjuvant activity in lymphoid tissues. Here, we covalently attached TLR-7/8a to polymers of varying composition, chain architecture and hydrodynamic behavior (∼300 nm submicrometer particles, ∼10 nm micelles and ∼4 nm flexible random coils) and evaluated how these parameters of polymer-TLR-7/8a conjugates impact adjuvant activity in vivo. Attachment of TLR-7/8a to any of the polymer compositions resulted in a nearly 10-fold reduction in systemic cytokines (toxicity). Moreover, both lymph node cytokine production and the magnitude of CD8 T cells induced against protein antigen increased with increasing polymer-TLR-7/8a hydrodynamic radius, with the submicrometer particle inducing the highest magnitude responses. Notably, CD8 T cell responses induced by polymer-TLR-7/8a were dependent on CCR2+ monocytes and IL-12, whereas responses by a small molecule TLR-7/8a that unexpectedly persisted in vaccine-site draining lymph nodes (T1/2 = 15 h) had less dependence on monocytes and IL-12 but required Type I IFNs. This study shows how modular properties of synthetic adjuvants can be chemically programmed to alter immunity in vivo through distinct immunological mechanisms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006667
003      
CZ-PrNML
005      
20200518132857.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.biomac.8b01473 $2 doi
035    __
$a (PubMed)30608149
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Lynn, Geoffrey M $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
245    10
$a Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction / $c GM. Lynn, P. Chytil, JR. Francica, A. Lagová, G. Kueberuwa, AS. Ishizuka, N. Zaidi, RA. Ramirez-Valdez, NJ. Blobel, F. Baharom, J. Leal, AQ. Wang, MY. Gerner, T. Etrych, K. Ulbrich, LW. Seymour, RA. Seder, R. Laga,
520    9_
$a Small molecule Toll-like receptor-7 and -8 agonists (TLR-7/8a) can be used as vaccine adjuvants to induce CD8 T cell immunity but require formulations that prevent systemic toxicity and focus adjuvant activity in lymphoid tissues. Here, we covalently attached TLR-7/8a to polymers of varying composition, chain architecture and hydrodynamic behavior (∼300 nm submicrometer particles, ∼10 nm micelles and ∼4 nm flexible random coils) and evaluated how these parameters of polymer-TLR-7/8a conjugates impact adjuvant activity in vivo. Attachment of TLR-7/8a to any of the polymer compositions resulted in a nearly 10-fold reduction in systemic cytokines (toxicity). Moreover, both lymph node cytokine production and the magnitude of CD8 T cells induced against protein antigen increased with increasing polymer-TLR-7/8a hydrodynamic radius, with the submicrometer particle inducing the highest magnitude responses. Notably, CD8 T cell responses induced by polymer-TLR-7/8a were dependent on CCR2+ monocytes and IL-12, whereas responses by a small molecule TLR-7/8a that unexpectedly persisted in vaccine-site draining lymph nodes (T1/2 = 15 h) had less dependence on monocytes and IL-12 but required Type I IFNs. This study shows how modular properties of synthetic adjuvants can be chemically programmed to alter immunity in vivo through distinct immunological mechanisms.
650    _2
$a adjuvancia imunologická $x aplikace a dávkování $x chemie $x farmakologie $7 D000276
650    _2
$a zvířata $7 D000818
650    _2
$a CD8-pozitivní T-lymfocyty $x účinky léků $x imunologie $7 D018414
650    _2
$a buněčné linie $7 D002460
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hydrodynamika $7 D057446
650    12
$a aktivace lymfocytů $7 D008213
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    12
$a micely $7 D008823
650    _2
$a vazba proteinů $7 D011485
650    _2
$a toll-like receptor 7 $x agonisté $7 D051199
650    _2
$a toll-like receptor 8 $x agonisté $7 D051200
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chytil, Petr $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského nám. 2 , 162 06 Prague 6 , Czech Republic.
700    1_
$a Francica, Joseph R $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
700    1_
$a Lagová, Anna $u Department of Oncology , University of Oxford , Old Road Campus Research Building , Oxford OX3 7DQ , United Kingdom.
700    1_
$a Kueberuwa, Gray $u Department of Oncology , University of Oxford , Old Road Campus Research Building , Oxford OX3 7DQ , United Kingdom.
700    1_
$a Ishizuka, Andrew S $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
700    1_
$a Zaidi, Neeha $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
700    1_
$a Ramirez-Valdez, Ramiro A $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
700    1_
$a Blobel, Nicolas J $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
700    1_
$a Baharom, Faezzah $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
700    1_
$a Leal, Joseph $u Department of Immunology , University of Washington , South Lake Union E-411, 750 Republican Street , Seattle , Washington 98109 , United States.
700    1_
$a Wang, Amy Q $u Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences , 9800 Medical Center Drive , Rockville , Maryland 20850 , United States.
700    1_
$a Gerner, Michael Y $u Department of Immunology , University of Washington , South Lake Union E-411, 750 Republican Street , Seattle , Washington 98109 , United States.
700    1_
$a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského nám. 2 , 162 06 Prague 6 , Czech Republic.
700    1_
$a Ulbrich, Karel $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského nám. 2 , 162 06 Prague 6 , Czech Republic.
700    1_
$a Seymour, Leonard W $u Department of Oncology , University of Oxford , Old Road Campus Research Building , Oxford OX3 7DQ , United Kingdom.
700    1_
$a Seder, Robert A $u Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, 40 Convent Drive , Bethesda , Maryland 20892 , United States.
700    1_
$a Laga, Richard $u Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského nám. 2 , 162 06 Prague 6 , Czech Republic. Department of Oncology , University of Oxford , Old Road Campus Research Building , Oxford OX3 7DQ , United Kingdom.
773    0_
$w MED00006456 $t Biomacromolecules $x 1526-4602 $g Roč. 20, č. 2 (2019), s. 854-870
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30608149 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132857 $b ABA008
999    __
$a ok $b bmc $g 1525525 $s 1096723
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 2 $d 854-870 $e 20190122 $i 1526-4602 $m Biomacromolecules $n Biomacromolecules $x MED00006456
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...